Affiliation:
1. Addictions, Drug and Alcohol Institute, University of Washington, Seattle, WA, USA
2. Gillian Schauer Consulting, Seattle, WA, USA
Abstract
Abstract
Introduction
As of January 2021, a total of 36 states and the District of Columbia (DC) have legalized medical cannabis use, and 14 states and DC have legalized adult nonmedical use. This manuscript qualitatively summarizes cannabis policies across states with legal adult use marketplaces.
Methods
Data are from state laws and regulations, collected through January 2021, and have been verified with state officials as part of ongoing state policy tracking efforts.
Results
State policies differ in how cannabis products are taxed, where revenues are allocated, restrictions on the types of available products, restrictions on additives and flavors, product packaging and labeling, advertising restrictions, where cannabis can be consumed, and approaches to social equity.
Conclusion
Timely, accurate, and longitudinal state and local cannabis policy data are needed to understand the implications of legalization. Careful study of policy differences across and within states is warranted, as differences may affect public health and consumer safety.
Funder
National Institute on Drug Abuse
Centers for Disease Control and Prevention
CDC Foundation
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology,General Medicine
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献